June 17, 2022
Zenabis Global Inc. & al. (the "Zenabis Group"), a medical and recreational cannabis cultivator which up until recently licensed approximately 1 million square feet of cultivation space in Atholville, New Brunswick, Stellarton, Nova Scotia, and Langley, British Columbia, obtained CCAA protection on June 17. The Zenabis Group was previously a publicly traded company on the TSX. On June 1, 2021, the Zenabis Group was acquired by Hexo Corp., which has been supporting the Zenabis Group's financial losses and providing operational and other support since that time. The Zenabis Group has consistently produced negative cash flows due to a variety of factors, including market pressures caused by the fragmentation of the overall cannabis industry and the resulting downwards pressure on margins and general operational and financial underperformance by the group. These factors were compounded by the financial pressures resulting from the group's obligations to its creditors, including its first ranking secured creditor, 2657408 Ontario Inc. The restructuring plan of the group will involve, among other things, the monetization of the current cannabis inventory of the Zenabis Group and the implementation of a SISP for the Atholville and Stellarton facilities. EY was appointed monitor. Counsel is Norton Rose for the Zenabis Group, Osler for the monitor and McCarthy Tétrault for the senior secured creditor.
By Dina Milivojevic